How Does Nabriva Therapeutics PLC - ADR (NBRV) Stock Rank on Wall Street Tuesday?

Tuesday, January 10, 2023 01:48 PM | InvestorsObserver Analysts

Mentioned in this article

How Does Nabriva Therapeutics PLC - ADR (NBRV) Stock Rank on Wall Street Tuesday?

Analysts who follow Nabriva Therapeutics PLC - ADR (NBRV) on average expect it to rise 444.22% over the next twelve months. Those same analysts give the stock an average rating of Buy. That average rating earns NBRV an Analyst Ranking of 35, which means it ranks higher than 35 of stocks, based on data compiled by InvestorsObserver.

Wall Street analysts are rating NBRV a Buy today. Find out what this means to you and get the rest of the rankings on NBRV!

See Full NBRV Report

Why are Analyst Ratings Important?

A company's financial statements are a significant factor weighted by experts when analyzing a company's health. Beyond just the numbers, analysts follow specific industries closely and are able to gain a detailed understanding of how a storm in one part of the world can shutdown supply chains leading to a change in consumption across the globe. This knowledge allows investors to respond to potential changes in the market before they are revealed in a quarterly annoucement. InvestorsObserver averages the ratings across all these analysts and percentile ranks those averages. This allows you to compare stocks in greater detail than the usual five-tiered system used amongst the majority of investors.

What's Happening With Nabriva Therapeutics PLC - ADR Stock Today?

Nabriva Therapeutics PLC - ADR (NBRV) stock is trading at $1.47 as of 1:34 PM on Tuesday, Jan 10, a gain of $0.11, or 8.09% from the previous closing price of $1.36. The stock has traded between $1.33 and $1.51 so far today. Volume today is 139,544 compared to average volume of 154,899. Click Here to get the full Stock Report for Nabriva Therapeutics PLC - ADR stock.